Published in Lotta Tuberc on April 26, 1967
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers. Am J Clin Pathol (1994) 1.52
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin. J Clin Microbiol (1995) 1.48
Immunohistologic analysis of mycobacterial antigens by monoclonal antibodies in tuberculosis and mycobacteriosis. Hum Pathol (1989) 1.41
Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol (2001) 1.27
Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis. Am J Respir Crit Care Med (1998) 1.22
Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med (1994) 1.20
Acute hepatitis complicating Mycoplasma pneumoniae infection. J Infect (1988) 1.07
Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. Am J Respir Crit Care Med (1999) 1.06
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection. AIDS Res Hum Retroviruses (1999) 1.01
Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate. Bone (1988) 1.00
Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis. Eur Cytokine Netw (2000) 0.98
Abdominal tuberculosis mimicking Crohn's disease: a difficult diagnosis. Report of a case. Panminerva Med (2002) 0.94
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability. J Infect Dis (2000) 0.94
Sarcoidosis in Europe: a cooperative study. Ann N Y Acad Sci (1976) 0.93
Discriminant analysis on small cell lung cancer and non-small cell lung cancer by means of NSE and CYFRA-21.1. Eur Respir J (1995) 0.92
Evaluation of a novel tuberculosis complex-specific 34 kDa protein in the serological diagnosis of tuberculosis. Eur Respir J (1995) 0.84
Pulmonary hamartoma. A rare case report. Panminerva Med (1999) 0.84
[Research on plasma levels of vitamin A and beta-carotene in gastrectomized tuberculotics]. Ann Ist Carlo Forlanini (1966) 0.82
Spiral CT and endoscopic findings in a case of tracheobronchopathia osteochondroplastica. J Comput Assist Tomogr (1997) 0.82
[Occult gastric adenocarcinoma with pulmonary carcinomatous lymphangitis and microangiopathic hemolytic anemia in a young adult]. Schweiz Med Wochenschr (1985) 0.81
Pulmonary alveolar microlithiasis: review of Italian reports. Eur J Epidemiol (1997) 0.81
Antibody repertoire against the A60 antigen complex during the course of pulmonary tuberculosis. Eur Respir J (1993) 0.79
Minimal dose of aerosolized interferon-alpha in human subjects: biological consequences and side-effects. Eur Respir J (1996) 0.79
Density and localization of calcium channels of the L-type in human pulmonary artery. Clin Exp Hypertens (1998) 0.79
[The Rational basis of hyperreactivity of the integrated respiratory tract]. Acta Otorhinolaryngol Ital (1996) 0.79
Chronic obstructive pulmonary disease and associated patterns of memory decline. Dementia (1995) 0.78
Pulmonary microlithiasis. Report of two cases. Respiration (1997) 0.78
Hyperprealbuminemia, euthyroid hyperthyroxinemia, Zollinger-Ellison-like syndrome and hypercorticism in a pancreatic endocrine tumour. Acta Endocrinol (Copenh) (1989) 0.78
Carcinoembryonic antigen, tissue polypeptide antigen and neuron-specific enolase pleural levels used to classify small-cell and non-small-cell lung cancer patients by discriminant analysis. J Cancer Res Clin Oncol (1996) 0.77
Airway stenosis after tracheo-bronchial tuberculosis. Respir Med (1997) 0.77
M. Kansasii pulmonary disease in idiopathic CD4+ T-lymphocytopenia. Eur Respir J (1996) 0.77
Strongyloides stercoralis hyperinfection in a case of idiopathic pulmonary fibrosis. Panminerva Med (1996) 0.76
Malignant mesothelioma in subjects with Marfan's syndrome and Ehlers-Danlos syndrome: only an apparent association? Respiration (2000) 0.76
Identification of subpopulations of bronchitic patients for suitable therapy by a dynamic rheological test. Int J Clin Pharmacol Res (1989) 0.76
Pharmacological characterisation of Ca2+ channels of the L-type in human peripheral blood lymphocytes. Eur J Pharmacol (1996) 0.76
Expression of dopamine receptors in immune organs and circulating immune cells. Clin Exp Hypertens (1997) 0.76
Non-fibrous inorganic particles in bronchoalveolar lavage fluid of pottery workers. Occup Environ Med (1996) 0.75
Validation of an algorithm able to differentiate small-cell lung cancer (SCLC) from non-small-cell lung cancer (NSCLC) patients by means of a tumour marker panel: analysis of the errors. Br J Cancer (1997) 0.75
Age-related changes of the noradrenergic innervation of rat tracheo-bronchial tree and pulmonary vasculature. Mech Ageing Dev (1997) 0.75
[Bronchial papilloma and papillomatosis. Anatomoclinical contribution]. Bronches (1972) 0.75
[Chronic bilateral pleural effusion, ungual dystrophies and diffuse lymphoedema by systemic hypoplasia (author's transl)]. Poumon Coeur (1979) 0.75
Effects of methylprednisolone on sputum biochemical components in asthmatic bronchitis. Eur J Respir Dis (1984) 0.75
[Further observations on the experimental pulmonary changes induced by chronic inhalation of ceramic dusts]. Med Lav (1967) 0.75
[Metabolism and mode of action of morphazinamide. Experimental and clinical reports]. Lotta Tuberc (1972) 0.75
[Local and general endocrine and metabolic disorders in predisposition to respiratory diseases]. Arch Monaldi Mal Torace (1992) 0.75
Role of the HLA-DP gene in susceptibility to lung granulomas. Sarcoidosis (1993) 0.75
[Pseudomembranous colitis caused by the ingestion of colocynth]. Schweiz Med Wochenschr (1987) 0.75
Chemiluminescence measurement of phagocytic activity of pulmonary macrophages in sarcoid alveolitis. Respiration (1984) 0.75
[Hemolytic anemia secondary to taking cyanidanol: demonstration of the mechanism of the erythrocyte damage]. Schweiz Med Wochenschr (1986) 0.75
[Hepato-splenic and peritoneal tuberculosis. A difficult diagnosis]. Minerva Med (1998) 0.75
[Action of adriamycin on primary and metastatic pulmonary neoplasms and on neoplastic pleural effusions]. Atti Accad Med Lomb (1975) 0.75
Evaluation of response to chemotherapy in patients affected with non-small cell lung cancer by means of three tumour markers elaborated by discriminant analysis. Respir Med (1997) 0.75
[Mycobacterium tuberculosis. From the gene to the diagnosis]. Recenti Prog Med (1992) 0.75
[Initial results of an integrated treatment of inoperable lung cancer]. Radiol Med (1981) 0.75
[McLeod's syndrome. Diagnostic value of pulmonary and bronchial angiographies, pulmonary vascular scintigraphy and some tests of the respiratory function]. Bronches (1976) 0.75
Munchausen's syndrome. A case of factitious hemoptysis. Panminerva Med (1999) 0.75
[Alveolar proteinosis secondary to pulmonary adenocarcinoma (secondary pneumopathy with amylaceous bodies). Anatomoclinical and histochemical study of a case]. Arch De Vecchi Anat Patol (1965) 0.75
[Anergic miliary tuberculosis, with principally splenic localization simulating hemolymphopathy. Report of 4 cases]. Minerva Med (1982) 0.75
[More elevated and prolonged blood levels of total and nonacetylated isoniazid by simultaneous venous perfusion of para-aminosalicylic acid and isoniazid]. Acta Tuberc Pneumol Belg (1969) 0.75
[New therapeutic strategies in influenza infections in patients at risk. Controlled study of ribavirin]. Clin Ter (1987) 0.75
[Multicenter clinical study on the delayed use of ipratropium-fenoterol in broncho-obstructive pathology]. Arch Monaldi (1984) 0.75
Efficacy and tolerability of brodimoprim in respiratory tract infections. J Chemother (1993) 0.75
[Various clinical and neoplastic pulmonary alveolar syndromes. Primary and secondary (non metastatic) forms]. Med Thorac (1967) 0.75
[Complete sclerocicatricial stenosis of the main right bronchios due to traumatic rupture. (Bronchial resection-anastomosis after two years, followed by functional respiratory recovery)]. Bronches (1973) 0.75
[Tracheal fibrolipoma of poor symptomatology revealed by a spirographic anomaly: endoscopic exeresis]. Bronches (1966) 0.75
Histological and histochemical pattern of phytohemagglutinin (PHA) skin test in patients with sarcoidosis. Z Erkr Atmungsorgane (1977) 0.75
The immunological events leading to the "in vitro" response to PPD. Allergol Immunopathol (Madr) (1987) 0.75
Tracheobronchial involvement in 84 cases of pulmonary tuberculosis. Monaldi Arch Chest Dis (1995) 0.75
[Therapy of pulmonary bacterial infections with amoxicillin and clavulanic acid: clinical experience]. Arch Monaldi Mal Torace (1989) 0.75
[Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug]. G Ital Mal Torace (1969) 0.75
Clinical study on bronchodilation induced by a metered aerosol of fenoterol in combination with ipratropium bromide. Respiration (1986) 0.75
[Caplans' "nodules" in aseptic necrotic evolution]. G Ital Mal Torace (1969) 0.75
[Determination of the aerobic capacity of Italians. I. Values for the students of the Accademia Militare di Modena]. Arch Sci Biol (Bologna) (1969) 0.75
Endoscopic findings in arytenoid sarcoidosis. Sarcoidosis (1994) 0.75
[Histiocytosis X. New histochemical data]. Poumon Coeur (1970) 0.75
[Pulmonary carcinoma in "miller's lung"]. G Ital Mal Torace (1969) 0.75
[Usefulness of mediastinoscopy in the diagnosis of ileo-mediastinal sarcoidotic adenopathies]. Haematologica (1970) 0.75
[Areactive pulmonary and systemic tuberculosis in a idiopathic thrombocythemia with immunodepression]. Arch Monaldi (1984) 0.75
[Experimental and clinico-therapeutic research with terizidone in tuberculosis]. Minerva Med (1968) 0.75
Diffuse interstitial lung diseases: a histochemical approach. Respiration (1984) 0.75
[Sarcoidosis, today]. Ann Ital Med Int (1990) 0.75
[Determination of the aerobic capacity of Italians. II. Values for urban police of the city of Modena]. Arch Sci Biol (Bologna) (1969) 0.75
Recurrent, fatal pulmonary embolism despite inferior vena cava interruption with the Greenfield filter. Vasa (1987) 0.75
[Pulmonary giant cell carcinoma]. Recenti Prog Med (1968) 0.75
[Diffuse pulmonary adenomatosis. Diagnostic contribution of viscosimetry of the sputum]. Bronchopneumologie (1981) 0.75
[Farmer's lung or Ramazzini's disease]. Med Lav (1985) 0.75
Severe subglottid stenosis, well-tolerated for many years. Monaldi Arch Chest Dis (1994) 0.75
[Frequency and characters of familial pulmonary sarcoidosis (author's transl)]. Z Erkr Atmungsorgane (1977) 0.75
[Treatment of mycobacteriosis]. Medicina (Firenze) (1990) 0.75
[Rifamycin SV in the therapy of tuberculosis]. Clin Ter (1966) 0.75
Evaluation of the response to chemotherapy in patients affected with small cell lung cancer using discriminant analysis: a preliminary report. Q J Nucl Med (1995) 0.75
[Hemodynamic and hemogasometric data on subclavian-pulmonary anastomosis in the dog]. Arch Chir Torac Cardiovasc (1970) 0.75
[Tuberculosis and mycobacteriosis in HIV-1 infection]. Recenti Prog Med (1990) 0.75
[McLeod's pneumodystrophy]. Recenti Prog Med (1984) 0.75
[Clinical study on 42 cases of mediastino-pulmonary sarcoidosis]. Haematologica (1970) 0.75
Spontaneous hydropneumothorax by severe pulmonary sarcoidosis. Sarcoidosis (1984) 0.75